微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 7.14% | -31.81% | 33.96% | 43/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 5.33% | -34.44% | 63% | 32/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 3.27% | -16.58% | -68.13% | 20/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 10.26% | 32.9% | -2.01% | 28/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 10.47% | 7.72% | 28.78% | 25/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 8.13% | 39.69% | 107.4% | 16/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 3.92% | 90.29% | -49.22% | 26/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 7.72% | 19.88% | -20.58% | 74/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 9.72% | 50.7% | 67.01% | 56/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 5.82% | 55.61% | 182.52% | 64/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 2.06% | 6.74% | -68.01% | 69/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 6.44% | -17.33% | -0.16% | 100/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 6.45% | 13.76% | 72.46% | 83/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 3.74% | 25.93% | 93.78% | 94/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 1.93% | 31.29% | -75.22% | 76/129 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 7.79% | -76.32% | 37.39% | 98/129 | 25.82% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 5.67% | -80.15% | 90.91% | 64/129 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 2.97% | -83.55% | 102.04% | 86/129 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 1.47% | 2% | -95.53% | 52/129 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 32.9% | -23.61% | 15.2% | 11/129 | 14.38% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 28.56% | 2% | 58.14% | 1/129 | 10.49% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 18.06% | 2% | -58.07% | 4/129 | 6.73% | 心脉医疗 | 31.04% | 行业排名> |
| 2018-12-31 | 43.07% | -17.84% | -17.84% | 3/129 | 12.98% | 新华医疗 | 13.55% | 行业排名> |
| 2017-12-31 | 52.42% | 182.74% | 182.74% | 2/129 | 13.82% | 安旭生物 | 48.71% | 行业排名> |
| 2016-12-31 | 18.54% | 2% | 2% | 27/129 | 16.21% | 迈瑞医疗 | 38.33% | 行业排名> |